Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study

1 Aug 2022

Abstract excerpt

Background and objectives Myasthenia gravis (MG) is a T cell-driven, autoantibody-mediated disorder affecting transmission in neuromuscular junctions. The associations between the peripheral T cells and MG have been extensively studied. However, they are mainly of observational nature, thus limiting our understanding of the effect of inflammatory biomarkers on MG risk. With large data sets now available, we used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Hormones and Disorders
Share to Autoimmune Neurological Disorders and Treatments
Share to Myasthenia Gravis and Thymoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35979348
DOI: 10.3389/fimmu.2022.931821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization studyPMID 35979348Read ↗

Circulating inflammatory cytokines and the risk of myasthenia gravis: a bidirectional Mendelian randomization studySemantic proximity Read ↗

Exploring the causal relationship between inflammatory cytokines and myasthenia gravis: A two-way Mendelian randomization study.Semantic proximity Read ↗

Mitochondrial proteins contribute to the pathogenesis of myasthenia gravis.Semantic proximity Read ↗

Genetic basis of myasthenia gravis - a comprehensive review.Semantic proximity Read ↗

Assessing the potential causal influence of myasthenia gravis on neurodegenerative diseases via multivariable Mendelian randomization.Semantic proximity Read ↗

Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis.Semantic proximity Read ↗

Genomic Insights into Myasthenia Gravis Identify Distinct Immunological Mechanisms in Early and Late Onset Disease.Semantic proximity Read ↗

Elucidating genetic backgrounds of myasthenia gravis in Japanese by genome-wide association studies and multi-omics analyses of thymoma.Semantic proximity Read ↗

Genetic and mechanistic overlap between Alzheimer’s disease and myasthenia gravis: insights into neuro-immune crosstalkSemantic proximity Read ↗

A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patientsSemantic proximity Read ↗

Causal relationship between the immune phenotype of monocytes and myasthenia gravis: A Mendelian randomization studySemantic proximity Read ↗

Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.